Investor insights
Sectors invested in
Funding rounds participated in
$15M sweet spot round size
Most of their 28 investments are in rounds between $6.4M and $22M
Investor type
Basic info
Industry
Sectors
Date founded
2005
Investments made
F-star Therapeutics, Inc. raised $15M on November 20, 2020
Investors: M Ventures, S.R. One Ltd, Atlas Venture and Aescap
Orphazyme A/S raised $95M on November 24, 2017
Investors: EQT Life Sciences, Novo Holdings, Idinvest Partners, Sunstone Life Science Ventures and Aescap
Orphazyme A/S raised $15M on March 8, 2017
Investors: Novo Holdings, Idinvest Partners, ALS Investment Fund, Sunstone Life Science Ventures and Aescap
I-Optics raised $15M on May 22, 2015
Investors: IPF Partners, De Hoge Dennen Capital, HBM Partners AG and Aescap
Orphazyme A/S raised $24M on January 9, 2015
Investors: Idinvest Partners, Sunstone Life Science Ventures and Aescap
Avantium raised $52M on May 22, 2014
Investors: The Coca-Cola Company, De Hoge Dennen Capital, Capricorn Venture Partners, Sofinnova Partners and Aescap
F-star Therapeutics, Inc. raised $9.4M on October 23, 2013
Investors: TVM Life Science Management Inc, MP Healthcare Venture Management Inc, Atlas Venture, S.R. One Ltd, M Ventures and Aescap
Orphazyme A/S raised $20M on September 7, 2011
Investors: Sunstone Life Science Ventures, Novo Holdings and Aescap
Avantium raised $64M on June 9, 2011
Investors: Navitas Capital, Sofinnova Ventures, Russia technology fund, De Hoge Dennen Capital and Aescap
F-star Therapeutics, Inc. raised $22M on April 13, 2011
Investors: MP Healthcare Venture Management Inc, TVM Life Science Management Inc, Atlas Venture, S.R. One Ltd, M Ventures and Aescap